Farms.com Home   News

Some SD Farmers Unhappy With Industrial Ag Getting Conservation Funds

By Mike Moen

Agriculture accounts for more than 10% of greenhouse-gas emissions in the United States. Advocates for small farms in South Dakota hope the next Farm Bill curbs spending for industrial operations linked to those emissions.

Like many sectors, "ag" is under pressure to reduce its carbon footprint. Congress recently punted reauthorization of the Farm Bill, which maps out spending for many farm and food-aid programs - to 2024.

Aaron Johnson, an organic producer south of Madison, hopes when lawmakers ramp up the debate, they take a closer look at conservation funding and where the money has been flowing.

"Nationwide," he said, "I see some abuse with the EQIP program and these biodigesters, that are just not functional unless they are heavily subsidized, by taxpayers and by the Farm Bill."

Johnson was referring to the Environmental Quality Incentives Program, which funds biodigesters. They capture methane from manure at factory farms, converting it to energy sources. According to the National Sustainable Agriculture Coalition, it's the most expensive program practice and does more harm than good. But large operators contend they're responding to the demand for safely grown meat, and are always working to modernize environmental practices.

Click here to see more...

Trending Video

Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Video: Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Regulations help markets and industry exist on level playing fields, keeping consumers safe and innovation from going too far. However, incredibly strict regulations can stunt innovation and cause entire industries to wither away. Dr. Peter James Facchini brings his perspective on how existing regulations have slowed the advancement of medical developments within Canada. Given the international concern of opium poppy’s illicit potential, Health Canada must abide by this global policy. But with modern technology pushing the development of many pharmaceuticals to being grown via fermentation, is it time to reconsider the rules?

Dr. Peter James Facchini leads research into the metabolic biochemistry in opium poppy at the University of Calgary. For more than 30 years, his work has contributed to the increased availability of benzylisoquinoline alkaloid biosynthetic genes to assist in the creation of morphine for pharmaceutical use. Dr. Facchini completed his B.Sc. and Ph.D. in Biological Sciences at the University of Toronto before completing Postdoctoral Fellowships in Biochemistry at the University of Kentucky in 1992 & Université de Montréal in 1995.